Forcyte Biotechnologies
Pre-clinicalDevelops cell-based therapies for tissue regeneration and repair using proprietary cellular engineering platforms.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $7.2M
About
Develops cell-based therapies for tissue regeneration and repair using proprietary cellular engineering platforms.
Cell TherapyRegenerative Medicine
Funding History
12Total raised:$7.2M
Seed$4MJan 15, 2023
Grant$42KApr 7, 2022
Grant$350KSep 14, 2021
Grant$353KJun 14, 2021